75,095 Shares in Zynex, Inc. (NASDAQ:ZYXI) Bought by LSV Asset Management

LSV Asset Management acquired a new position in Zynex, Inc. (NASDAQ:ZYXI - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 75,095 shares of the company's stock, valued at approximately $818,000. LSV Asset Management owned approximately 0.22% of Zynex at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Mainstay Capital Management LLC ADV bought a new position in Zynex during the fourth quarter valued at approximately $118,000. Connors Investor Services Inc. raised its position in Zynex by 4.3% in the 3rd quarter. Connors Investor Services Inc. now owns 24,250 shares of the company's stock worth $194,000 after purchasing an additional 1,000 shares during the period. GSA Capital Partners LLP lifted its stake in Zynex by 23.6% in the third quarter. GSA Capital Partners LLP now owns 113,117 shares of the company's stock worth $905,000 after purchasing an additional 21,577 shares during the last quarter. Bridge City Capital LLC boosted its position in Zynex by 7.0% during the third quarter. Bridge City Capital LLC now owns 140,532 shares of the company's stock valued at $1,124,000 after buying an additional 9,241 shares during the period. Finally, Trexquant Investment LP grew its stake in shares of Zynex by 146.3% during the third quarter. Trexquant Investment LP now owns 83,806 shares of the company's stock valued at $670,000 after buying an additional 49,775 shares during the last quarter. 29.68% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ZYXI. Royal Bank of Canada raised their price target on Zynex from $13.00 to $15.00 and gave the stock an "outperform" rating in a research report on Friday, March 1st. HC Wainwright restated a "buy" rating and issued a $21.00 target price on shares of Zynex in a report on Wednesday, May 1st.

Zynex Trading Up 1.5 %

Shares of NASDAQ:ZYXI traded up $0.15 during midday trading on Friday, hitting $10.49. 162,008 shares of the stock traded hands, compared to its average volume of 224,512. The company has a quick ratio of 2.87, a current ratio of 3.58 and a debt-to-equity ratio of 1.76. The stock has a market capitalization of $333.27 million, a PE ratio of 44.96 and a beta of 0.49. Zynex, Inc. has a one year low of $6.88 and a one year high of $13.77. The business's 50 day moving average is $12.05 and its two-hundred day moving average is $10.93.

Zynex (NASDAQ:ZYXI - Get Free Report) last released its quarterly earnings results on Thursday, February 29th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.17 by ($0.13). The business had revenue of $47.28 million for the quarter, compared to the consensus estimate of $54.53 million. Zynex had a net margin of 4.33% and a return on equity of 16.34%. The company's revenue for the quarter was down 3.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.20 EPS. As a group, research analysts forecast that Zynex, Inc. will post 0.51 earnings per share for the current year.

Zynex Profile

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.